Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma - Results from a prospective interventional case series

Julia Lüke*, Khaled Nassar, Matthias Lüke, Salvatore Grisanti

*Corresponding author for this work
26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma - Results from a prospective interventional case series'. Together they form a unique fingerprint.

Medicine and Dentistry